Contact
Please use this form to send email to PR contact of this press release:
Bondarenko Acquires 16.2% Beneficial Ownership of BriaCell Therapeutics Corp.
TO:
Please use this form to send email to PR contact of this press release:
Bondarenko Acquires 16.2% Beneficial Ownership of BriaCell Therapeutics Corp.
TO: